Shares of Advanced Accelerator Application SA (NASDAQ:AAAP) were up 3% on Wednesday . The company traded as high as $36.00 and last traded at $34.23, with a volume of 127,391 shares trading hands. The stock had previously closed at $33.22.

A number of analysts recently weighed in on AAAP shares. Zacks Investment Research downgraded shares of Advanced Accelerator Application SA from a “buy” rating to a “sell” rating in a research report on Tuesday, June 28th. Canaccord Genuity restated a “buy” rating on shares of Advanced Accelerator Application SA in a report on Tuesday, May 31st. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $35.67.

The stock’s 50 day moving average price is $31.54 and its 200-day moving average price is $31.83. The firm’s market cap is $1.23 billion.

Advanced Accelerator Applications SA is a radiopharmaceutical company that develops, produces and sells molecular nuclear medicine (MNM), diagnostic and therapeutic products. The Company’s lead therapeutic candidate, Lutathera, is being developed for the treatment of midgut neuroendocrine tumors (NETs).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.